Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-51.78	23.88	49.53
Graham Fair Price	44.63	9.20	6.36
PEG	-81.59	0.10	-0.53
Price/Book	14.29	0.58	0.51
Price/Cash Flow	-54.14	15.92	34.71
Prices/Earnings	-43.10	10.73	18.86
Price/Sales	-42.86	1.71	2.99
Price/FCF	-54.14	15.92	34.71
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-1.69	0.45	0.46
Operating Margin	1.81	0.06	0.06
ROA	100.87	< 0.005	< 0.005
ROE	< 0.005	0.01	100.87
ROIC	< 0.005	0.01	101.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.06	1.09	-94.79
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.52	1.04	100.79
EPS QOQ	-0.35	1.09	209.09
FCF QOQ	0.17	1.49	758.91
Revenue QOQ	-0.38	1.00	162.17
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	58.63	28.90	-50.70
Days Sales Outstanding (DSO)	138.75	98.76	-28.82
Inventory Turnover	1.54	3.11	102.85
Debt/Capitalization	0.33	0.25	-26.31
Quick Ratio	0.45	0.58	28.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	16.36	16.70	2.05
Cash	2.10	2.17	3.21
Capex	-0.11	-0.22	-104.09
Free Cash Flow	0.24	0.61	154.30
Revenue	2.78	5.67	104.09
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.76	0.76	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	21.03	8.92	-57.57
Naive Interpretation	Member

06 - Financial Health · Bad

Rating